コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 biological systems have hindered functional glycoproteomics.
2 ts and assist informatics decision-making in glycoproteomics.
3 elanoma samples, and mass spectrometry-based glycoproteomics.
4 fic glycosylation sites in mass spectrometry-glycoproteomics.
5 way for high-throughput multiprotein plasma glycoproteomics.
6 w modified phase of hydrophilic materials in glycoproteomics.
7 is a step closer to comprehensive automated glycoproteomics.
8 ze the full potential of extended mass range glycoproteomics.
9 dges but not by HILIC to enable quantitative glycoproteomics.
10 loped so far provide important insights into glycoproteomics.
11 implications for the application of FAIMS in glycoproteomics.
12 of the most daunting hurdles in the field of glycoproteomics.
13 position of the glycan at specific sites via glycoproteomics.
14 eRATOR presents exciting opportunities for O-glycoproteomics.
15 rometry-based qualitative and quantitative N-glycoproteomics.
16 isticated intact glycopeptide analysis using glycoproteomics.
17 rter in superresolution microscopy, chemical glycoproteomics, a genome-wide CRISPR-knockout (CRISPR-K
22 reatment to live cells, followed by MS-based glycoproteomics analysis, to assess changes in protein g
29 opeptide level is of importance in bottom-up glycoproteomics and an indispensable step to understand
31 onstrating its highly sensitive and specific glycoproteomics and phosphorproteomics analysis in compl
35 a mass spectrometry workflow, quantitative O-glycoproteomics, and global proteomics to identify 663 G
36 as time goes, the accumulation of glycomics, glycoproteomics, and glycan-binding data has reached a p
37 logical techniques combined with proteomics, glycoproteomics, and glycomics revealed that a lack of P
38 of sites of protein glycosylation; targeted glycoproteomics; and functional glycoproteomics, with a
39 d substantial processing differences using a glycoproteomics approach by comparing CD16a isolated fro
42 conditions to up to 1500 with our optimized glycoproteomics approach, highlighting the need for tail
48 s it possible to comprehensively interrogate glycoproteomics data and illuminate the many roles of gl
51 ally developed for classifying glycomics and glycoproteomics data, so we modified it to be well-suite
53 tact glycopeptides have produced large-scale glycoproteomics datasets, but interpreting these data re
54 lute quantification of glycans are needed in glycoproteomics, during development and production of bi
55 mplement the surfaceome data with whole cell glycoproteomics enabled by a recently developed techniqu
56 ysis using machine learning, drug discovery, glycoproteomics, extracellular vesicle proteomics, and s
57 ntegrating enzymatic treatment with MS-based glycoproteomics for analyzing cell surface glycoproteins
59 f site-specific protein glycobiology through glycoproteomics has evolved rapidly in recent years than
60 opments in glycobiology, glycochemistry, and glycoproteomics have made the field more manageable and
63 et al. (2017) provides a novel algorithm for glycoproteomics in which complex glycopeptides can be id
64 ults were variable, several high-performance glycoproteomics informatics strategies were identified.
67 ectrometry methods (CE-MS) for glycomics and glycoproteomics is limited by the lack of convenient int
70 matography (LC)-mass spectrometry (MS)-based glycoproteomics method in combination with highly specif
71 we describe the important role that chemical glycoproteomics methods are playing in such efforts.
75 c glycoprotein reporter system and performed glycoproteomics on endogenous parasite glycoproteins usi
76 lycans, has been a persistent challenge in O-glycoproteomics owing to the technical challenges surrou
77 present IsoTaG, a mass-independent chemical glycoproteomics platform for characterization of intact,
78 ort that the addition of IMS to conventional glycoproteomics platforms adds additional information re
80 all proteins in the PDB with a corresponding glycoproteomics profile, for a total of 4,259 N-glycosyl
82 nd a combination of sensitive proteomics and glycoproteomics readouts, we documented the progressive
83 ven the structural analysis of glycoproteins-glycoproteomics-remains in its infancy due to the scarci
85 sensitive sheathless CE-ESI-MS approaches in glycoproteomics research, by significantly improving sen
88 MMP-9 null mice (n=8 per group) analyzed by glycoproteomics showed that of 541 N-glycosylated protei
89 ill one of the greatest challenges in modern glycoproteomics, since multiple regio- and stereoisomers
90 udy, comprising both developers and users of glycoproteomics software, evaluates solutions for system
92 ectin enrichment) and improves large-scale N-glycoproteomics studies due to greatly reduced sample co
94 ader than the distribution expected from the glycoproteomics studies, assuming that glycan processing
95 ger than those obtained from the "bottom-up" glycoproteomics studies, suggesting that the glycoproteo
99 nt in C. jejuni, we utilized high throughput glycoproteomics to characterize C. jejuni JHH1 and ident
101 eceptor from newborn calf serum, carried out glycoproteomics to define the N-glycans at its 19 potent
102 mbined with sensitive and quantitative O-Man glycoproteomics to identify a homologous family of four
103 lycopeptides to select peptides for targeted glycoproteomics using directed MS and (ii) mass-independ
104 ch that includes genomics, proteomics, and O-glycoproteomics was used to characterize cross-talk betw
105 his technology and expand its usefulness for glycoproteomics, we have developed and improved methods
109 trument functions is especially important in glycoproteomics, where complexities of glycopeptide frag
110 on; targeted glycoproteomics; and functional glycoproteomics, with a focus on probing interactions be
111 ta acquisition modes currently available for glycoproteomics within a rapid Top Speed DDA duty cycle.
113 ver, the reported use of PASEF in integrated glycoproteomics workflows to comprehensively capture the